Yohei Ichimura

2.0k total citations
69 papers, 1.6k citations indexed

About

Yohei Ichimura is a scholar working on Pathology and Forensic Medicine, Dermatology and Immunology. According to data from OpenAlex, Yohei Ichimura has authored 69 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Pathology and Forensic Medicine, 26 papers in Dermatology and 25 papers in Immunology. Recurrent topics in Yohei Ichimura's work include Systemic Sclerosis and Related Diseases (63 papers), Mast cells and histamine (17 papers) and Dermatologic Treatments and Research (14 papers). Yohei Ichimura is often cited by papers focused on Systemic Sclerosis and Related Diseases (63 papers), Mast cells and histamine (17 papers) and Dermatologic Treatments and Research (14 papers). Yohei Ichimura collaborates with scholars based in Japan, United States and Italy. Yohei Ichimura's co-authors include Yoshihide Asano, Shinichi Sato, Takashi Taniguchi, Takehiro Takahashi, Tetsuo Toyama, Kaname Akamata, Shinji Noda, Ryosuke Saigusa, Takashi Yamashita and Makoto Sugaya and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Yohei Ichimura

67 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yohei Ichimura Japan 25 1.1k 620 409 409 277 69 1.6k
Tetsuo Toyama Japan 26 1.2k 1.1× 604 1.0× 463 1.1× 434 1.1× 318 1.1× 84 1.7k
Zenshiro Tamaki Japan 21 928 0.9× 495 0.8× 451 1.1× 347 0.8× 424 1.5× 53 1.7k
Kaname Akamata Japan 22 853 0.8× 413 0.7× 370 0.9× 325 0.8× 240 0.9× 48 1.3k
Takashi Yamashita Japan 21 627 0.6× 429 0.7× 290 0.7× 260 0.6× 204 0.7× 70 1.2k
Pravitt Gourh United States 17 888 0.8× 441 0.7× 244 0.6× 245 0.6× 239 0.9× 19 1.4k
Eloisa Romano Italy 23 749 0.7× 338 0.5× 528 1.3× 336 0.8× 206 0.7× 70 1.6k
Kouki Nakamura Japan 18 496 0.5× 356 0.6× 288 0.7× 249 0.6× 171 0.6× 57 1.0k
Benjamin D. Korman United States 17 433 0.4× 367 0.6× 268 0.7× 190 0.5× 138 0.5× 36 1.2k
Shinichi Masuguchi Japan 21 428 0.4× 363 0.6× 828 2.0× 332 0.8× 160 0.6× 62 1.6k
Paulius Venalis Sweden 12 375 0.3× 256 0.4× 531 1.3× 177 0.4× 268 1.0× 16 1.3k

Countries citing papers authored by Yohei Ichimura

Since Specialization
Citations

This map shows the geographic impact of Yohei Ichimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohei Ichimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohei Ichimura more than expected).

Fields of papers citing papers by Yohei Ichimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohei Ichimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohei Ichimura. The network helps show where Yohei Ichimura may publish in the future.

Co-authorship network of co-authors of Yohei Ichimura

This figure shows the co-authorship network connecting the top 25 collaborators of Yohei Ichimura. A scholar is included among the top collaborators of Yohei Ichimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yohei Ichimura. Yohei Ichimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miura, Shunsuke, Yohei Ichimura, Uri Sela, et al.. (2023). Staphylococcus Aureus and Streptococcus Pyogenes Induce Psoriasis-Related Transcriptomes Augmented by IL-17A and TNF-α. Journal of Investigative Dermatology. 143(8). 1613–1617.e5. 9 indexed citations
2.
Ichimura, Yohei, Takuya Miyagawa, Yuki Fukui, et al.. (2021). The Contribution of LIGHT (TNFSF14) to the Development of Systemic Sclerosis by Modulating IL-6 and T Helper Type 1 Chemokine Expression in Dermal Fibroblasts. Journal of Investigative Dermatology. 142(6). 1541–1551.e3. 3 indexed citations
3.
Sugaya, Makoto, et al.. (2021). Case of bullous pemphigoid under treatment with adalimumab for hidradenitis suppurativa. The Journal of Dermatology. 48(4). e163–e164. 5 indexed citations
4.
Miura, Shunsuke, Yoshihide Asano, Ryosuke Saigusa, et al.. (2020). Regulation of skin fibrosis by RALDH1-producing dermal dendritic cells via retinoic acid-mediated regulatory T cell induction: A role in scleroderma. Journal of Dermatological Science. 97(2). 125–134. 8 indexed citations
5.
6.
Hirabayashi, Megumi, Yoshihide Asano, Takashi Yamashita, et al.. (2017). Possible pro‐inflammatory role of heparin‐binding epidermal growth factor‐like growth factor in the active phase of systemic sclerosis. The Journal of Dermatology. 45(2). 182–188. 6 indexed citations
7.
Miyagawa, Takuya, Yoshihide Asano, Ryosuke Saigusa, et al.. (2017). Serum H‐ficolin levels: Clinical association with interstitial lung disease in patients with systemic sclerosis. The Journal of Dermatology. 44(10). 1168–1171. 9 indexed citations
8.
Takahashi, Takehiro, Yoshihide Asano, Koji Sugawara, et al.. (2017). Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma. The Journal of Experimental Medicine. 214(4). 1129–1151. 65 indexed citations
9.
Taniguchi, Takashi, Takuya Miyagawa, Zenshiro Tamaki, et al.. (2017). A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis. Archives of Dermatological Research. 309(10). 833–842. 10 indexed citations
10.
Toyama, Tetsuo, Yoshihide Asano, Kaname Akamata, et al.. (2015). Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells. Journal of Investigative Dermatology. 136(2). 387–398. 20 indexed citations
11.
Taniguchi, Takashi, Yoshihide Asano, Kaname Akamata, et al.. (2014). Fibrosis, Vascular Activation, and Immune Abnormalities Resembling Systemic Sclerosis in Bleomycin‐Treated Fli‐1–Haploinsufficient Mice. Arthritis & Rheumatology. 67(2). 517–526. 77 indexed citations
12.
Ichimura, Yohei, Yoshihide Asano, Kaname Akamata, et al.. (2014). Serum Angiopoietin-like Protein 3 Levels: Possible Correlation with Progressive Skin Sclerosis, Digital Ulcers and Pulmonary Vascular Involvement in Patients with Systemic Sclerosis. Acta Dermato Venereologica. 94(2). 157–162. 10 indexed citations
13.
Ichimura, Yohei, Yoshihide Asano, Kaname Akamata, et al.. (2013). Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis. Archives of Dermatological Research. 306(4). 331–338. 44 indexed citations
14.
Noda, Shinichi, Yoshihide Asano, Toshiyuki Takahashi, et al.. (2013). Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis. Lara D. Veeken. 52(5). 790–799. 34 indexed citations
15.
Noda, Shinji, Yoshihide Asano, Naohiko Aozasa, et al.. (2012). Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis. Archives of Dermatological Research. 305(4). 325–331. 12 indexed citations
16.
Masui, Yuri, Yoshihide Asano, Takehiro Takahashi, et al.. (2012). Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosis. Modern Rheumatology. 23(2). 323–329. 22 indexed citations
17.
Noda, Shinji, Yoshihide Asano, Kaname Akamata, et al.. (2012). A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis. PLoS ONE. 7(2). e32272–e32272. 35 indexed citations
18.
19.
Ichimura, Yohei, Yoshihide Asano, Masaru Hatano, et al.. (2011). Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene. Modern Rheumatology. 21(5). 548–552. 9 indexed citations
20.
Miyagaki, Tomomitsu, Makoto Sugaya, Mayumi Nagata, et al.. (2011). Oral erosive lichen planus associated with thymoma treated with etretinate. Australasian Journal of Dermatology. 54(1). e25–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsuo Toyama Breakdown of academic impact, for papers by Zenshiro Tamaki Breakdown of academic impact, for papers by Kaname Akamata Breakdown of academic impact, for papers by Takashi Yamashita Breakdown of academic impact, for papers by Pravitt Gourh Breakdown of academic impact, for papers by Eloisa Romano Breakdown of academic impact, for papers by Kouki Nakamura Breakdown of academic impact, for papers by Benjamin D. Korman Breakdown of academic impact, for papers by Shinichi Masuguchi Breakdown of academic impact, for papers by Paulius Venalis
Rankless by CCL
2026